FDA Panel Backs Emergency Use For Pfizer COVID-19 Vaccine
A U.S. Food and Drug Administration advisory committee voted Thursday to approve an emergency use authorization request from Pfizer and BioNTech for their COVID-19 vaccine, potentially clearing the way for some...To view the full article, register now.
Already a subscriber? Click here to view full article